Rigel and Bristol-Myers Squibb Announce Research and Development Collaboration for TGF Beta Receptor Kinase Inhibitors for Use in Immuno-Oncology Related Indications

Feb 23, 2015, 08:03 ET from Rigel Pharmaceuticals, Inc.

$countyNameToPathMap.put("sp